MENTA CAPITAL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
MENTA CAPITAL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2018$427,000
+1.4%
3,725
-35.3%
0.15%
+67.4%
Q1 2018$421,000
-27.7%
5,760
-42.5%
0.09%
-21.2%
Q4 2017$582,000
-53.1%
10,025
-63.7%
0.11%
-37.9%
Q3 2017$1,240,000
-37.9%
27,625
-45.4%
0.18%
-23.2%
Q2 2017$1,996,000
+50.0%
50,551
+10.1%
0.24%
+29.5%
Q2 2016$1,331,000
+177.9%
45,900
+235.0%
0.18%
+177.3%
Q1 2016$479,000
-29.5%
13,700
-34.8%
0.07%
-38.3%
Q3 2015$679,00021,0190.11%
Other shareholders
HAEMONETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders